Copio, Pablita S.

HRN: 29-34-34  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/25/2026
CIPROFLOXACIN 2MG/ML, 100ML IV
07/25/2026
08/01/2026
IV
400mg
Q12
UTI
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: